Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NUVB on NYSE
Shares outstanding
339,200,672
Price per share
$5.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
211,301,697
Total reported value
$1,892,897,581
% of total 13F portfolios
0.01%
Share change
-12,006,288
Value change
-$57,153,731
Number of holders
219
Price from insider filings
$5.34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nuvation Bio Inc. - Common Stock (NUVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $110,306,310 +$11,583,764 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $42,332,244 +$10,273,842 21,708,843 +32% BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 219 institutional investors reported holding 211,301,697 shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 62% of the company’s total 339,200,672 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Nuvation Bio Inc. - Common Stock (NUVB) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 51,424,981 +1.7% 0.02% $460,767,830
Decheng Capital LLC 7.7% 25,954,439 0% 31% $232,551,773
BlackRock, Inc. 7.3% 24,669,776 +0.27% 0% $221,041,196
VANGUARD GROUP INC 4.6% 15,555,606 +0.65% 0% $139,378,229
Omega Fund Management, LLC 2.4% 8,081,089 -8.5% 25% $72,406,557
Laurion Capital Management LP 2.3% 7,852,638 -19% 4.8% $70,359,636
STATE STREET CORP 1.7% 5,858,782 -3.8% 0% $52,494,687
GEODE CAPITAL MANAGEMENT, LLC 1.7% 5,712,296 -3% 0% $51,191,720
TANG CAPITAL MANAGEMENT LLC 1.1% 3,857,457 -8.2% 1.7% $34,562,815
ABRAMS CAPITAL MANAGEMENT, L.P. 1.1% 3,811,513 0% 0.6% $34,151,156
BANK OF AMERICA CORP /DE/ 1.1% 3,809,425 +505% 0% $34,132,448
Redmile Group, LLC 0.93% 3,163,256 +4.4% 2.1% $28,342,774
Nuveen, LLC 0.84% 2,852,001 -38% 0.01% $25,553,930
PRICE T ROWE ASSOCIATES INC /MD/ 0.8% 2,708,553 +852% 0% $24,270,000
DIMENSIONAL FUND ADVISORS LP 0.61% 2,066,360 -38% 0% $18,514,586
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.59% 2,016,681 -1.9% 0% $18,069,462
NORTHERN TRUST CORP 0.57% 1,921,732 -9.3% 0% $17,218,719
GOLDMAN SACHS GROUP INC 0.5% 1,696,013 +41% 0% $15,196,276
AQR CAPITAL MANAGEMENT LLC 0.49% 1,669,166 -18% 0.01% $14,955,727
Capricorn Fund Managers Ltd 0.47% 1,588,854 3.4% $14,236,132
Knoll Capital Management, LLC 0.44% 1,498,591 +46% 6.2% $13,427,375
Qube Research & Technologies Ltd 0.38% 1,280,899 0.02% $11,476,855
MORGAN STANLEY 0.38% 1,276,128 -3.3% 0% $11,434,107
ARMISTICE CAPITAL, LLC 0.37% 1,263,737 -45% 0.28% $11,323,084
SymBiosis Capital Partners, LLC 0.37% 1,250,000 0% 12% $11,200,000

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 211,301,697 $1,892,897,581 -$57,153,731 $8.96 219
2025 Q3 220,565,926 $817,904,643 -$1,514,062 $3.70 202
2025 Q2 224,729,650 $439,155,420 +$34,613,471 $1.95 179
2025 Q1 207,335,118 $364,911,263 +$18,852,443 $1.76 159
2024 Q4 197,748,566 $526,027,669 +$38,581,638 $2.66 159
2024 Q3 187,137,100 $428,593,958 +$73,128,321 $2.29 153
2024 Q2 153,048,262 $446,948,909 +$52,594,408 $2.92 146
2024 Q1 134,652,746 $490,113,918 +$5,142,866 $3.64 122
2023 Q4 134,270,272 $202,718,680 -$2,287,216 $1.51 116
2023 Q3 136,892,011 $183,439,434 -$9,239,486 $1.34 122
2023 Q2 139,011,387 $250,194,724 +$3,219,600 $1.80 120
2023 Q1 137,479,282 $228,214,660 -$4,709,474 $1.66 126
2022 Q4 139,580,600 $267,992,788 -$12,224,298 $1.92 123
2022 Q3 141,780,239 $317,588,133 -$44,323,294 $2.24 116
2022 Q2 155,298,098 $503,167,223 -$21,514,875 $3.24 116
2022 Q1 159,104,350 $836,898,347 +$14,198,236 $5.26 112
2021 Q4 155,258,449 $1,319,350,594 +$21,011,876 $8.50 103
2021 Q3 151,280,175 $1,503,381,648 +$33,688,697 $9.94 97
2021 Q2 147,981,823 $1,364,632,796 +$15,849,184 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,836,329 $10.45 72